Curebase has added real-world data and artificial intelligence experts to its advisory board in a bid to capture a greater share of the decentralized trials market.

The biotech industry has not caught the ESG bug that has swept across C-suites in recent years as part of the broad push for corporate social responsibility.

Yumanity Therapeutics is cutting 60% of its workforce by April, while not-so-subtly asking for buyers as the neurodegenerative-focused biotech’s early promise begins to fade.

Just a few days after Peter Guenter joined Merck KGaA as its healthcare CEO at the beginning of 2021, the 22-year Sanofi veteran found himself picking up the pieces from a major setback: Then-GlaxoSmithKline-partnered bispecific antibody bintrafusp alfa failed to outdo Merck & Co.’s PD-1 king Keytruda in a high-profile head-to-head trial in non-small cell lung cancer.

John Mascola, M.D., director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, is retiring at the end of March after more than eight years at the helm, a stint that most notably included collaboration with Moderna on its COVID-19 vaccine.

Mirati Therapeutics was already a few quarters behind Amgen in the KRAS race after the May 2021 Lumakras approval. Now, the biotech could be 19 months behind Amgen in getting its non-small cell lung cancer (NSCLC) drug approved.

Sage and Biogen’s depression drug quickly relieved symptoms of depression in a phase 3 trial, but the readout did little to quell concerns about the med’s durability of effect, an issue that investors and analysts have been concerned about.

Cytokinetics’ heart failure treatment has no impact on improving exercise capacity, according to a phase 3 trial.

While many companies developing blood tests and genomic analyses for cancer are aiming to improve early diagnosis, most of Veracyte’s tests focus on the journey that comes after.

Biotechs do not have the arsenal of antibiotic hopefuls in their pipelines to match the growing threat of antimicrobial resistance, according to a new BIO report (PDF) published Monday.